The small molecule inhibitor 5-fluoro-2-indolyl des-chlorohalopemide (FIPI), blocks PLD1 and PLD2 activity, effectively suppressing bleb formation in the HT1080 Fibrosarcoma cell line [77]. Here, PLD1 is linked to fibrosarcoma.